PT1253935E - Parafuso com cabeca especialmente adaptada a uma ponteira de preensao e de aparafusamento - Google Patents
Parafuso com cabeca especialmente adaptada a uma ponteira de preensao e de aparafusamentoInfo
- Publication number
- PT1253935E PT1253935E PT01902406T PT01902406T PT1253935E PT 1253935 E PT1253935 E PT 1253935E PT 01902406 T PT01902406 T PT 01902406T PT 01902406 T PT01902406 T PT 01902406T PT 1253935 E PT1253935 E PT 1253935E
- Authority
- PT
- Portugal
- Prior art keywords
- pressure
- especially adapted
- fitting point
- cabinet screw
- screw especially
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Clamps And Clips (AREA)
- Pressure Vessels And Lids Thereof (AREA)
- Dowels (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0002527A GB0002527D0 (en) | 2000-02-04 | 2000-02-04 | Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction |
US23659400P | 2000-09-29 | 2000-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1253935E true PT1253935E (pt) | 2006-08-31 |
Family
ID=26243563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01902406T PT1253935E (pt) | 2000-02-04 | 2001-02-05 | Parafuso com cabeca especialmente adaptada a uma ponteira de preensao e de aparafusamento |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1253935B1 (pt) |
JP (1) | JP4969753B2 (pt) |
AT (1) | ATE324905T1 (pt) |
AU (2) | AU4643501A (pt) |
DE (1) | DE60119285T2 (pt) |
DK (1) | DK1253935T3 (pt) |
ES (1) | ES2263582T3 (pt) |
PT (1) | PT1253935E (pt) |
WO (2) | WO2001057181A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040023863A1 (en) * | 2000-04-06 | 2004-02-05 | Franco Wayne P. | Methods of use growth factors for treating heart disease |
US20050026220A1 (en) * | 2001-08-10 | 2005-02-03 | Shahin Rafii | Isolation and mobilization of stem cells expressing vegfr-1 |
ITRM20020119A1 (it) * | 2002-03-05 | 2003-09-05 | Geymonat Spa | Composizioni contenenti plgf ad uso farmaceutico e cosmetico. |
JP4741249B2 (ja) | 2002-11-16 | 2011-08-03 | シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー | 心血管疾患における生化学的マーカーの組合せとしてのsCD40L,PAPP−Aおよび胎盤増殖因子(PlGF) |
EP2295449A1 (en) | 2009-09-09 | 2011-03-16 | Dompe PHA.R.MA S.p.A. | PLGF-1 in homodimeric form |
EP3586867A3 (en) * | 2013-01-28 | 2020-04-08 | Shire Human Genetic Therapies, Inc. | Placenta growth factor in treating duchenne muscular dystrophy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121246A (en) * | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
WO1998007832A1 (en) * | 1996-08-23 | 1998-02-26 | Ludwig Institute For Cancer Research | Recombinant vascular endothelial cell growth factor d (vegf-d) |
NZ514872A (en) * | 1997-04-25 | 2005-01-28 | Collateral Therapeutics | Truncated VEGF-B, VRF-2, VEGF-C, PlGF, VEGF-3, poxvirus ORF-1 and poxvirus ORF-2 proteins |
GB2332373A (en) * | 1997-12-19 | 1999-06-23 | Merck & Co Inc | Treatment of coronary and/or peripheral ischemia using an antithrombotic agent and an angiogenesis promoter |
CN1295617A (zh) * | 1998-02-06 | 2001-05-16 | 科莱特诺医疗公司 | 血管生成因子-血管内皮细胞生长因子vegf的突变体 |
-
2001
- 2001-02-02 WO PCT/EP2001/001659 patent/WO2001057181A2/en unknown
- 2001-02-02 AU AU46435/01A patent/AU4643501A/en not_active Withdrawn
- 2001-02-05 AU AU2001230243A patent/AU2001230243A1/en not_active Abandoned
- 2001-02-05 ES ES01902406T patent/ES2263582T3/es not_active Expired - Lifetime
- 2001-02-05 DE DE60119285T patent/DE60119285T2/de not_active Expired - Lifetime
- 2001-02-05 PT PT01902406T patent/PT1253935E/pt unknown
- 2001-02-05 WO PCT/EP2001/001208 patent/WO2001056593A2/en active IP Right Grant
- 2001-02-05 AT AT01902406T patent/ATE324905T1/de active
- 2001-02-05 DK DK01902406T patent/DK1253935T3/da active
- 2001-02-05 EP EP01902406A patent/EP1253935B1/en not_active Expired - Lifetime
- 2001-02-05 JP JP2001556492A patent/JP4969753B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2001230243A1 (en) | 2001-08-14 |
AU4643501A (en) | 2001-08-14 |
WO2001057181A2 (en) | 2001-08-09 |
ATE324905T1 (de) | 2006-06-15 |
WO2001056593A3 (en) | 2002-04-25 |
DE60119285D1 (de) | 2006-06-08 |
EP1253935A2 (en) | 2002-11-06 |
ES2263582T3 (es) | 2006-12-16 |
DK1253935T3 (da) | 2006-09-04 |
EP1253935B1 (en) | 2006-05-03 |
WO2001056593A2 (en) | 2001-08-09 |
DE60119285T2 (de) | 2007-05-10 |
JP2003521522A (ja) | 2003-07-15 |
JP4969753B2 (ja) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50091B (sr) | Upotreba retigabina u lečenju neuropatskog bola | |
DE69939370D1 (de) | Medizinischer artikel aus unterschiedlich hergestelltem kollagen-biomaterial | |
DE60231395D1 (de) | Dezellularisierung von gewebematrixen | |
FR2822664B1 (fr) | Etagere pour le support d'articles, en particulier dans des installations refrigerees | |
CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
RS51478B (sr) | Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove kombinacije lekova | |
PT1253935E (pt) | Parafuso com cabeca especialmente adaptada a uma ponteira de preensao e de aparafusamento | |
FI931204A0 (fi) | Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat | |
WO2003087353A3 (en) | Purified polypeptides involved in membrane biogenesis | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
AR028411A1 (es) | Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos | |
MX9304070A (es) | Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. | |
FI973184A0 (fi) | Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa | |
EA199900579A1 (ru) | Применение ингибиторов комт для производства лекарственного средства для профилактики сосудистых дисфункций при диабете | |
ATE401337T1 (de) | Antiangiogene polypeptide | |
IS5231A (is) | Vefjaþáttur sem hefur áhrif á blóðæðarmyndun | |
WO2002057281A3 (en) | Aminoglycosides as antibiotics | |
MXPA04000418A (es) | Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas. | |
ECSP045161A (es) | Piperidin-2,6-diona sustituida con heterociclo en la posición 3 | |
ATE443695T1 (de) | Doppelester | |
UA32315A (uk) | Спосіб накладання шкірного шва | |
NO20016326L (no) | Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet | |
UA32280A (uk) | Спосіб формування тонко-товстокишкового анастомозу бік у бік | |
DE50302713D1 (de) | Folientasche zur Aufnahme von Verbandzeug | |
UA24697C2 (uk) | Лікарський засіб прямої антикоагулянтної та фібринолітичної дії |